StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lipella Pharmaceuticals's price to book ratio was 0.0× on Oct 19, 2026, against 0.7× a year earlier. Over the last 4 years it ranged from 0.0× to 8.5×, with a median of 1.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.0×−0.6
2025Dec 31, 20250.6×−1.7
2024Dec 31, 20242.3×−0.4
2023Dec 29, 20232.7×−5.8
2022Dec 30, 20228.5×–

More Lipella Pharmaceuticals figures

See a number that looks wrong?